Evidence map›Paper›PMID 38682028›Full record

ArticleOphthalmology science

Artificial Intelligence to Differentiate Pediatric Pseudopapilledema and True Papilledema on Fundus Photographs.

Melinda Y Chang, Gena Heidary, Shannon Beres, Stacy L Pineles, Eric D Gaier, Ryan Gise, Mark Reid, Kleanthis Avramidis, Mohammad Rostami, Shrikanth Narayanan

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Agreement and Accuracy of Papilledema and Pseudopapilledema Classification Among Pediatric Neuro-Ophthalmologists Using Optic Disc Photographs.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2025
    Observational
  8. Article
  9. Article
  10. Article
  11. Distinguishing Papilledema from Pseudopapilledema in Children.Advances in ophthalmology and optometry · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Melinda Y ChangDivision of Ophthalmology, Children's Hospital Los Angeles, Los Angeles, California.
Gena HeidaryDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts.
Shannon BeresDepartment of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California.
Stacy L PinelesDepartment of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles, California.
Eric D GaierDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts.
Ryan GiseDepartment of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts.
Mark ReidDivision of Ophthalmology, Children's Hospital Los Angeles, Los Angeles, California.
Kleanthis AvramidisViterbi School of Engineering, University of Southern California, Los Angeles, California.
Mohammad RostamiViterbi School of Engineering, University of Southern California, Los Angeles, California.
Shrikanth NarayananViterbi School of Engineering, University of Southern California, Los Angeles, California.

Funding

Pediatric Eye Disease Investigator Group Coordinating CenterU10EY011751 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI KRAKER, RAYMOND · 1997 to 2018
$75.2M
Ophthalmic Therapeutics Engineering CoreP30EY029220 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Sun Young Lee · 2018 to 2026
$6.5M
Biomarkers of Vision Loss in Children with Optic Pathway GliomasR01EY029687 · NEI · CHILDREN'S HOSP OF PHILADELPHIA · PI AVERY, ROBERT ANDREW · 2019 to 2023
$3.3M
Exploiting principles of timing-dependent synaptic plasticity to treat amblyopiaK08EY030164 · NEI · BOSTON CHILDREN'S HOSPITAL · PI GAIER, ERIC DEAN · 2019 to 2023
$1.2M
Validating a machine learning model of eye tracking in children with cortical visual impairment (CVI)K23EY033790 · NEI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI Melinda Chang · 2022 to 2026
$1.2M
Physical Injuries in Patients with Pediatric Eye DiseasesR21EY029655 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PINELES, STACY · 2019 to 2020
$429k
NEI NIH HHS K08 EY030164NEI NIH HHS K23 EY033790NEI NIH HHS P30 EY029220NEI NIH HHS R01 EY029687NEI NIH HHS R21 EY029655NEI NIH HHS U10 EY011751
6 · The paper itself

Abstract

Purpose: To develop and test an artificial intelligence (AI) model to aid in differentiating pediatric pseudopapilledema from true papilledema on fundus photographs. Design: Multicenter retrospective study. Subjects: A total of 851 fundus photographs from 235 children (age < 18 years) with pseudopapilledema and true papilledema. Methods: Four pediatric neuro-ophthalmologists at 4 different institutions contributed fundus photographs of children with confirmed diagnoses of papilledema or pseudopapilledema. An AI model to classify fundus photographs as papilledema or pseudopapilledema was developed using a DenseNet backbone and a tribranch convolutional neural network. We performed 10-fold cross-validation and separately analyzed an external test set. The AI model's performance was compared with 2 masked human expert pediatric neuro-ophthalmologists, who performed the same classification task. Main Outcome Measures: Accuracy, sensitivity, and specificity of the AI model compared with human experts. Results: The area under receiver operating curve of the AI model was 0.77 for the cross-validation set and 0.81 for the external test set. The accuracy of the AI model was 70.0% for the cross-validation set and 73.9% for the external test set. The sensitivity of the AI model was 73.4% for the cross-validation set and 90.4% for the external test set. The AI model's accuracy was significantly higher than human experts on the cross validation set ( Conclusions: When classifying fundus photographs of pediatric papilledema and pseudopapilledema, our AI model achieved > 90% sensitivity at detecting papilledema, superior to human experts. Due to the high sensitivity and low false negative rate, AI may be useful to triage children with suspected papilledema requiring work-up to evaluate for serious underlying neurologic conditions. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

artificial intelligencefundus photographspapilledemapediatricpseudopapilledema

Identifiers

PMID38682028
PMCPMC11046195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.